Company Filing History:
Years Active: 2015
Title: Sibel Nur Gunay: Innovator in Glycan Research
Introduction
Sibel Nur Gunay is a prominent inventor based in Chestnut Hill, MA (US). She has made significant contributions to the field of glycan research, particularly through her innovative methods related to modified glycans. Her work has implications for various applications in biochemistry and pharmaceuticals.
Latest Patents
Sibel Nur Gunay holds 1 patent that focuses on methods for enriching, identifying, and quantifying unusually modified glycans. This patent includes techniques for handling glycans that have been treated to release sialic acids. The methods involve separating glycans based on their charge-to-mass ratio and quantifying the resulting products using specific quantification standards.
Career Highlights
Sibel is currently employed at Momenta Pharmaceuticals, Inc., where she applies her expertise in glycan research to advance the company's pharmaceutical innovations. Her work is crucial in developing new therapeutic strategies that leverage the unique properties of modified glycans.
Collaborations
Throughout her career, Sibel has collaborated with notable colleagues, including Carlos J Bosques and Jennifer Murphy. These collaborations have enriched her research and contributed to the advancement of glycan-related technologies.
Conclusion
Sibel Nur Gunay's contributions to glycan research exemplify the impact of innovative thinking in the field of biochemistry. Her patent and work at Momenta Pharmaceuticals, Inc. highlight her role as a key figure in advancing scientific knowledge and applications in this area.